
Danish University Approves Controversial Hepatitis B Trial in Guinea-Bissau Despite Ethical Protests
The University of Southern Denmark has approved a controversial clinical trial in Guinea-Bissau that will withhold the hepatitis B birth vaccine from half of 14,000 newborns. The study, backed by the US CDC and Health Secretary Robert F. Kennedy Jr., has faced intense international criticism for ethical violations and potential harm to infants. While the trial was previously suspended, recent funding allocations and revised protocols have allowed it to move forward, raising concerns about the exploitation of vulnerable populations.













